LENZING AG/ AT0000644505 /
24/06/2024 10:36:42 | Chg. -0.050 | Volume | Bid10:36:42 | Demandez à10:36:42 | Capitalisation boursière | Dividende Y. | Rapport P/E |
---|---|---|---|---|---|---|---|
33.900EUR | -0.15% | - Chiffrre d'affaires: - |
33.900Bid taille: - | 34.150Ask la taille: - | 1.1 Mrd.EUR | - | - |
GlobeNewswire
10:30
REPEAT – Metasphere Labs Enters a Definitive Agreement with ARCannabis to Develop VR Virtual Store
GlobeNewswire
10:00
OPEN Health and fusion announce partnership to deliver AI-powered healthcare communications
GlobeNewswire
10:00
TDOC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Teladoc Health, Inc. Investors...
GlobeNewswire
10:00
INTC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Intel Corporation Investors wi...
GlobeNewswire
09:53
Novotech Appoints Dr. Ian Braithwaite as Vice President, Global Project Management to Lead World-Cla...
GlobeNewswire
09:00
Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Ant...
GlobeNewswire
08:39
OKX Marketplace and Astra Nova Launch Giveaway of 500 SuperNova NFT Whitelist Spots and 50 Shards
GlobeNewswire
08:00
First gene therapy for prevalent pathologies in neurology receives FDA IND clearance - EG 427 initi...
GlobeNewswire
07:30
PolTREG’s type-1 diabetes Treg cell therapy PTG-007 demonstrates long-term safety and efficacy for u...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page